UBS AM’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-158,669
| Closed | -$346K | – | 2917 |
|
|
2021
Q3 | $346K | Hold |
158,669
| – | – | ﹤0.01% | 2594 |
|
|
2021
Q2 | $595K | Sell |
158,669
-30,267
| -16% | -$105K | ﹤0.01% | 2465 |
|
|
2021
Q1 | $616K | Buy |
188,936
+40,864
| +28% | +$146K | ﹤0.01% | 2312 |
|
|
2020
Q4 | $505K | Buy |
148,072
+31,304
| +27% | +$129K | ﹤0.01% | 2300 |
|
|
2020
Q3 | $476K | Buy |
116,768
+25,276
| +28% | +$96.1K | ﹤0.01% | 2167 |
|
|
2020
Q2 | $309K | Buy |
91,492
+8,750
| +11% | +$25.5K | ﹤0.01% | 2271 |
|
|
2020
Q1 | $193K | Buy |
82,742
+954
| +1% | +$2.61K | ﹤0.01% | 2288 |
|
|
2019
Q4 | $298K | Buy |
81,788
+12,650
| +18% | +$102K | ﹤0.01% | 2370 |
|
|
2019
Q3 | $574K | Buy |
69,138
+13,943
| +25% | +$113K | ﹤0.01% | 2220 |
|
|
2019
Q2 | $475K | Buy |
55,195
+1,729
| +3% | +$15.5K | ﹤0.01% | 2233 |
|
|
2019
Q1 | $572K | Buy |
53,466
+7,257
| +16% | +$77.7K | ﹤0.01% | 2057 |
|
|
2018
Q4 | $404K | Sell |
46,209
-13,156
| -22% | -$168K | ﹤0.01% | 2085 |
|
|
2018
Q3 | $997K | Hold |
59,365
| – | – | ﹤0.01% | 1813 |
|
|
2018
Q2 | $1.24M | Sell |
59,365
-430
| -0.7% | -$7.97K | ﹤0.01% | 1723 |
|
|
2018
Q1 | $962K | Buy |
59,795
+3,717
| +7% | +$73.6K | ﹤0.01% | 1801 |
|
|
2017
Q4 | $1.06M | Buy |
56,078
+15,746
| +39% | +$285K | ﹤0.01% | 1724 |
|
|
2017
Q3 | $567K | Buy |
40,332
+755
| +2% | +$6.83K | ﹤0.01% | 1902 |
|
|
2017
Q2 | $295K | Buy |
39,577
+16,179
| +69% | +$106K | ﹤0.01% | 2044 |
|
|
2017
Q1 | $152K | Hold |
23,398
| – | – | ﹤0.01% | 2248 |
|
|
2016
Q4 | $104K | Sell |
23,398
-24,500
| -51% | -$103K | ﹤0.01% | 2247 |
|
|
2016
Q3 | $224K | Hold |
47,898
| – | – | ﹤0.01% | 2407 |
|
|
2016
Q2 | $315K | Hold |
47,898
| – | – | ﹤0.01% | 2207 |
|
|
2016
Q1 | $305K | Sell |
47,898
-174
| -0.4% | -$893 | ﹤0.01% | 2205 |
|
|
2015
Q4 | $290K | Buy |
48,072
+12,100
| +34% | +$69.2K | ﹤0.01% | 2351 |
|
|
2015
Q3 | $215K | Hold |
35,972
| – | – | ﹤0.01% | 2451 |
|
|
2015
Q2 | $246K | Buy |
35,972
+1,600
| +5% | +$10.2K | ﹤0.01% | 2488 |
|
|
2015
Q1 | $209K | Buy |
34,372
+2,500
| +8% | +$16.6K | ﹤0.01% | 2466 |
|
|
2014
Q4 | $221K | Hold |
31,872
| – | – | ﹤0.01% | 2425 |
|
|
2014
Q3 | $259K | Hold |
31,872
| – | – | ﹤0.01% | 2233 |
|
|
2014
Q2 | $259K | Hold |
31,872
| – | – | ﹤0.01% | 2271 |
|
|
2014
Q1 | $250K | Buy |
31,872
+3,400
| +12% | +$28.8K | ﹤0.01% | 2301 |
|
|
2013
Q4 | $252K | Sell |
28,472
-3,600
| -11% | -$32.2K | ﹤0.01% | 2249 |
|
|
2013
Q3 | $269K | Hold |
32,072
| – | – | ﹤0.01% | 2151 |
|
|
2013
Q2 | $239K | Buy |
+32,072
| New | +$246K | ﹤0.01% | 2161 |
|
Other funds holding SPPI
AC
UBS AM's SPPI Position: Q4 2021 in Review
UBS AM sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q4 2021, closing a stake of 158,669 shares — an estimated $346K sold.
UBS AM first reported a position in SPPI in Q2 2013 and held it in 34 quarters. The position peaked at $1.24M in Q2 2018. 142 funds tracked by Wall St. Rank hold SPPI as of Q4 2021.
- UBS AM reported no remaining Spectrum Pharmaceuticals Inc position as of Q4 2021 after selling out during the quarter.
- UBS AM sold 158,669 Spectrum Pharmaceuticals Inc shares in Q4 2021, an estimated $346K.
- UBS AM first reported a position in Spectrum Pharmaceuticals Inc in Q2 2013 and held it in 34 quarters.
- UBS AM's Spectrum Pharmaceuticals Inc position peaked at $1.24M in Q2 2018.
- 142 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q4 2021.
Based on UBS AM's 13F filing for Q4 2021, filed 14 Feb 2022.